Acute and 28-Day Subchronic Oral Toxicity of an Ethanol Extract of Zingiber zerumbet (L.) Smith in Rodents

被引:16
作者
Chang, Chia Ju [1 ]
Tzeng, Thing-Fong [2 ]
Liou, Shorong-Shii [3 ,4 ]
Chang, Yuan-Shiun [1 ]
Liu, I-Min [3 ,4 ]
机构
[1] China Med Univ, Sch Chinese Pharmaceut Sci & Chinese Med Resource, Taichung 40402, Taiwan
[2] Pao Chien Hosp, Dept Internal Med, Ping Tung City 90064, Pingtung County, Taiwan
[3] Tajen Univ, Dept Pharm, Yanpu Shiang 90701, Ping Tung Shien, Taiwan
[4] Tajen Univ, Grad Inst Pharmaceut Technol, Yanpu Shiang 90701, Ping Tung Shien, Taiwan
关键词
TOXICOLOGICAL EVALUATION; GINGER;
D O I
10.1155/2012/608284
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
The objective of this study was to evaluate the acute and subacute toxicity (28 days) of the ethanol extract of Z. zerumbet rhizomes (EEZZ) via the oral route in Wistar rats of both sexes. In the acute toxicity study, Wistar rats were administered a single dose of 15 g kg(-1) of body weight by gavage, and were monitored for 14 days. EEZZ did not produce any toxic signs or deaths; the 50% lethal dose must be higher than 15 g kg(-1). In the subchronic toxicity study, EEZZ was administered by gavage at doses of 1000, 2000 and 3000 mg/kg daily for 4 weeks to Wistar rats. The subacute treatment with EEZZ did not alter either the body weight gain or the food and water consumption. The hematological and biochemical analysis did not show significant differences in any of the parameters examined in female or male groups. Necropsy and histopathological examination, did not reveal any remarkable and treatment related changes. A no-observed adverse-effect level for EEZZ is 3000 mg kg(-1) for rats under the conditions of this study. Hence, consumption of EEZZ for various medicinal purposes is safe.
引用
收藏
页数:11
相关论文
共 26 条
  • [11] Langner E, 1998, ADV THER, V15, P25
  • [12] LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
  • [13] Nalawade SM, 2003, BOT BULL ACAD SINICA, V44, P79
  • [14] OECD 107, 1995, GUID TEST CHEM
  • [15] Concordance of the toxicity of pharmaceuticals in humans and in animals
    Olson, H
    Betton, G
    Robinson, D
    Thomas, K
    Monro, A
    Kolaja, G
    Lilly, P
    Sanders, J
    Sipes, G
    Bracken, W
    Dorato, M
    Van Deun, K
    Smith, P
    Berger, B
    Heller, A
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2000, 32 (01) : 56 - 67
  • [16] Raza M., 2002, SCI PHARM, V7, P135
  • [17] Saidu Y., 2007, Asian Journal of Biochemistry, V2, P224
  • [18] SiewKiat T, 2006, SUNWAY ACAD J, V3, P1
  • [19] Somchit M. N., 2005, IJP - International Journal of Pharmacology, V1, P277
  • [20] Stark J L, 1980, Nursing, V10, P33